10. Sympathomimetics and sympatholytics agents Flashcards
activation of α1 -receptor
✦ smooth muscle contraction
✦ vasoconstriction
✦ mydriasis
activation of α2 -receptor
✦ inhibition of neurotransmitter release (NA!)
✦ GI-relaxation
✦ inhibition of insulin release
activation of β1 -receptor
✦ positive inotropic and chronotropic effects
activation of β2 -receptor
✦ vasodilation
✦ bronchodilatation
✦ uterus relaxation
activation of β3 -receptor
✦ lipolysis in fat tissue
Pharmacological effect of sympathomimetic drugs. Cardiovascular system.
✦ positive chronotropic (β1)
✦ positive inotropic (β1)
✦ vasoconstriction (α1)
✦ vasodilatation (β2)
Pharmacological effect of sympathomimetic drugs. Gastrointestinal system
✦ smooth muscle relaxation
✦ GI atony
Pharmacological effect of sympathomimetic drugs. Respiratory system
✦ bronchodilatation
✦ decreased bronchial secretion
Pharmacological effect of sympathomimetic drugs. Urinary bladder
✦ increased sphincter-constriction (α1)
Pharmacological effect of sympathomimetic drugs. Eye
✦ mydriasis (iris radial muscles)
✦ increase in aqueous humor production
list of non-selective sympathomimetics
✦ adrenaline
✦ noradrenaline
✦ dopamine
Adrenaline (epinephrine). Indications
nonselective, mainy β1 and β2
arrhytmogenic!. Intratracheal/IV
Indications:
⋆ cardiac stop
⋆ severe bronchoconstriction
⋆ anaphylaxia
⋆ local vasoconstriction (haemorrhages)
⋆ increase in duration of local anaesthetics
Noradrenaline (norepinephrine). Indications
⋆ nonselective (mainly β1 and α1), cardiac effect
⋆ blood pressure is significantly increased!
Indication (rare): hypotension
Dopamine. Receptors?
low dose D1 - receptors (kidney!) → 2-5 µg/kg/min medium dose β1 - receptors (heart!) → 5-10 µg/kg/min high dose α1 - receptors (pressor) → 10-20 µg/kg/min
β1-adrenoceptor agonists
Dobutamine (mainly β1)
Isoproterenol (β1 and β2)
Dobutamine
mainly β1 receptors
indication: cardiogenic shock (IV. infusion)
Isoproterenol
β1 and β2
heart+bronchi+muscle vessels
Mainly β2 agonists:
bronchodilatation and uterus relaxation
higher dosage → β1 receptors → cardiac effect
⋆ clenbuterole
⋆ salbutamole
⋆ terbutaline
⋆ salmeterole
⋆ isoxsuprine
Indications for β2 agonists:
⋆ horse RAO
⋆ feline asthma
⋆ bronchitis,
⋆ bronchopneumonia
⋆ tracheal hypoplasia
⋆ tracheal collapse
Mainly α1 agonists
⋆ Phenylephrine (used rarely. vasoconstriction, usually local use: allergy, cold)
⋆ Xylometazoline, oxymetazoline (vasoconstriction, local usage)
⋆ Phenylpropanolamine (urinary bladder sphincter constriction!, PO usage)
⋆ Ephedrine (allergy, incontinence (p.o.))
α2 agonists
xylazine, detomidine, medetomidine, romifidine
Nonselective α-antagonists
Phenoxybenzamine (urethra sphincter relaxation)
Phentolamine
Tolazoline
α1 antagonists
prazosine, doxasozine (urethra sphincter relaxation)
α2 rec antagonists
atipamezole, yohimbine
Nonselective β-rec antagonists
Propranolole
Timolole
Selective β1 antagonists
Metoprolole
Atenolole
What is the α1-agonist drug we MUST know?
Ephedrine